Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: Biotech Showcase Conference

Sernova Corp. (SEOVF) Starts Presentation at Biotech Showcase Conference

Sernova Corp. (OTC: SEOVF) is a clinical stage regenerative medicine company focused on developing medical technologies for the treatment of chronic debilitating metabolic diseases such as diabetes, blood disorders including hemophilia and other diseases treated through replacement of proteins or … Continue reading

Posted in Biotech Showcase Conference | Leave a comment

Provectus Biopharmaceuticals, Inc. (PVCT) Starts Presentation at Biotech Showcase Conference

Provectus Biopharmaceuticals, Inc. (NYSE: PVCT) specializes in developing oncology and dermatology therapies. PV-10, the company’s novel investigational drug for cancer, is designed for injection into solid tumors, thereby reducing potential for systemic side effects. Its oncology focus is on melanoma, … Continue reading

Posted in Biotech Showcase Conference | Leave a comment

Pressure BioSciences, Inc. (PBIO) Starts Presentation at Biotech Showcase Conference

Pressure BioSciences, Inc. (OTC: PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. The company’s products are based on the unique properties of both constant and alternating (pressure cycling technology, or … Continue reading

Posted in Biotech Showcase Conference | Leave a comment

Intellipharmaceutics International, Inc. (IPCI) Starts Presentation at Biotech Showcase Conference

Intellipharmaceutics International, Inc. (NASDAQ: IPCI) is engaged in the research, development, and commercialization of controlled-release and targeted pharmaceutical products. Controlled-release means releasing a drug into the bloodstream or at a target site in the body, over an extended period of … Continue reading

Posted in Biotech Showcase Conference | Leave a comment

RedHill Biopharma Ltd. (RDHL) Starts Presentation at Biotech Showcase Conference

RedHill Biopharma Ltd. (NASDAQ: RDHL) is an Israeli biopharmaceutical company primarily focused on the development and commercialization of late clinical-stage drugs for the treatment of inflammatory and gastrointestinal diseases, including cancer. The company is working to develop proprietary, orally administered, … Continue reading

Posted in Biotech Showcase Conference | Leave a comment

OncBioMune Pharmaceuticals, Inc. (OBMP) Starts Presentation at Biotech Showcase Conference

OncBioMune Pharmaceuticals, Inc. (OTC: OBMP) is headquartered in Baton Rouge, Louisiana, and is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a proprietary vaccine technology that is designed to stimulate the immune system to … Continue reading

Posted in Biotech Showcase Conference | Leave a comment

Viking Therapeutics, Inc. (VKTX) Starts Presentation at Biotech Showcase Conference

Viking Therapeutics, Inc. (NASDAQ: VKTX) is a clinical stage biopharmaceutical company focused on the development of therapies for metabolic and endocrine disorders. The company has a portfolio that includes five therapeutic programs either in clinical trials or preclinical studies. Viking’s … Continue reading

Posted in Biotech Showcase Conference | Leave a comment

Relmada Therapeutics, Inc. (RLMD) Starts Presentation at Biotech Showcase Conference

Relmada Therapeutics, Inc. (OTC: RLMD) is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of pain. The … Continue reading

Posted in Biotech Showcase Conference | Leave a comment

DanDrit Biotech USA, Inc. (DDRT) Starts Presentation at Biotech Showcase Conference

DanDrit Biotech USA, Inc. (OTC: DDRT) was founded in 2001 and is focusing on the clinical development of a dendritic cell vaccine for treatment of colorectal cancer. DanDrit was founded based on the research of Professor Jesper Zeuthen at the … Continue reading

Posted in Biotech Showcase Conference | Leave a comment

Heat Biologics (HTBX) Starts Presentation at Biotech Showcase Conference

Heat Biologics (NASDAQ: HTBX) is developing novel therapies that activate a patient’s immune system against cancer. The company’s T cell-stimulating platform technologies, ImPACT and ComPACT, form the basis of its product candidates. In combination with other therapies, these platforms are … Continue reading

Posted in Biotech Showcase Conference | Leave a comment